The U.S. medical technology company St. Jude Medical Inc. reported a third-quarter profit decline. As is clear from a press release issued on Wednesday, the sales totalled $1.33 billion in comparison to the prior year’s $1.38 billion.
The net profit of the company from St. Paul, Minnessota, decreased to $176 million after a net profit of $227 million in the same period last year. Overall, they have achieved a rise in adjusted earnings thanks to strong growth in its core business. In the future the will focus more on improving efficiency and introducing new products.
St. Jude Medical manufactures medical devices for diseases of the heart and the nervous system. More than 14,000 employees work for St. Jude Medical.
[ilink url=“http://investors.sjm.com/phoenix.zhtml?c=73836&p=irol-newsArticle&ID=1746350″] Link zur Quelle (St. Jude Medical)[/ilink]